• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Immunological effect of CB-11mAb on intervertebral disc degeneration

Research Project

Project/Area Number 05671207
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Orthopaedic surgery
Research InstitutionTOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY

Principal Investigator

TSUJI Haruo  Toyama Medical and Pharmaceutical University Orthopaedics, Professor, 医学部・整形外科学, 教授 (90009449)

Co-Investigator(Kenkyū-buntansha) ISHIHARA H  Toyama Medical and Pharmaceutical University Orthopaedics Assist, Prof, 附属病院・整形外科, 助手 (30242499)
MATSUNO H  Toyama Medical and Pharmaceutical University Orthopaedics Assist, Prof, 医学部・整形外科学, 助手 (00219461)
Project Period (FY) 1993 – 1994
Project Status Completed (Fiscal Year 1994)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1994: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1993: ¥1,000,000 (Direct Cost: ¥1,000,000)
KeywordsMonoclonal antibody / Intervertebral disc / Immunology / Immunohistochemistry
Research Abstract

Type II collagen existing in the hyaline cartilage and nucleus pulposus of the intervertebral disc have a specific property as an isolated antigen for immunological reactions.
In considering the mechanism of intervertebral disc degeneration, annular rupture may provide contact with Type II collagen in the nucleus pulposus and the lymphocytes in vivo. In humans, not a few patients show severe multiple intervertebral disc degeneration irrespective of their clonological ages, suggesting an immulogical background to represent disc degeneration. From the experimental results of hyaline cartilage observation, CB-11 peptide of Type II collagen is a specific fragment of immunoreactivity of T II C.In this reserch project, mamy efforts have been paid to refine the specific monoclonal antibody of CB-11 peptide (CB-11mAb). The pilot study clarified that the CB-11mAb recognized the antigen epitope of T II C from the results of immunosuppressive efects of CB-11mAb on collagen-induced arthritis in mice. Using an ABC method, serial immunohistochemical sections from 12 fresh intervertebral discs (mainly nucleus pulposus with various grade of degeneration) obtained by surgery was reacted with the CB-11mAb. However, none of positive immunoreactivity of Type II collagen was observed in degenerated nucleus pulposus.
Thus the conclusion was drawn to be negligible on T II C immunologic mechanism on the process of intervertebral disc degeneration in humans.

Report

(3 results)
  • 1994 Annual Research Report   Final Research Report Summary
  • 1993 Annual Research Report
  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] 辻,松野,石原,根塚: "ヒト椎間板変性および椎間板ヘルニアにおけるCB-11モノクローナル抗体の免疫学的意義" 脊椎・脊髄ジャーナル. 8巻12号(発表予定). (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Matsuno,Nezuka,Tsuji: "Therapeutic effects of CB-11 monoclonal antibody in collagen-induced arthritis mice." Expert opinion on Investigational Drugs. (invited paper)(発表予定). (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Matsuno, Nezuka, Tsuji: "Therapeutic effects of CB-11 monoclonal antibody in collagen-induced arthritis mice." Expert opinion on Investigational Drugs invited paper. (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] 辻,松野,石原,根塚: "ヒト椎間板変性および椎間板ヘルニアにおけるCB-IIモノクローナル抗体の免疫学的意義" 脊椎・脊髄ジャーナル. 8巻12号(発表予定). (1995)

    • Related Report
      1994 Annual Research Report
  • [Publications] ,Matsuno,Nezuka,Tsuji: "Therapeutic effects of CB-IImonoclonal antibody in collagen-induced arthritis mice." Expert opinion on Investigational Drugs. invited paper(発表予定). (1995)

    • Related Report
      1994 Annual Research Report

URL: 

Published: 1993-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi